首页 | 本学科首页   官方微博 | 高级检索  
     

去唾液酸糖蛋白-人端粒酶逆转录酶-胸苷激酶/丙氧鸟苷的靶向促HepG2细胞凋亡作用及旁观者效应
引用本文:杨长青,邓志华,刘燕,刘京龙,曹燕. 去唾液酸糖蛋白-人端粒酶逆转录酶-胸苷激酶/丙氧鸟苷的靶向促HepG2细胞凋亡作用及旁观者效应[J]. 中华肝脏病杂志, 2008, 16(7): 509-513
作者姓名:杨长青  邓志华  刘燕  刘京龙  曹燕
作者单位:1. 山西医科大学第二医院消化科,太原,030001
2. 山西医科大学第二医院肿瘤实验室,太原,030001
摘    要:目的 观察去唾液酸糖蛋白(AF)-pGL3-人端粒酶逆转录酶(hTERT)-胸苷激酶(TK)对肝癌细胞株HepG2细胞生长及凋亡的影响.方法 培养细胞并构建pGL3-hTERT-TK质粒、AF脂质体复合物后,转染HepG2细胞和L02细胞,通过单光子液闪计数仪,脱氧核糖核苷酸末端转移酶介导的缺口末端标记法和流式细胞仪观察自杀基因对肝癌细胞生长和凋亡的影响,以及其对自杀基因的旁观者效应.结果 在肝癌细胞HepG2中,TK基因可以被hTERT启动子驱动高效的表达,而不影响正常肝细胞L02的生长,AF通过识别去唾液酸糖蛋白受体结合到HepG2细胞表面,其携带的TK基因更易进入肝癌细胞,同时增强自杀基因TK的高效表达,在旁观者效应机制的参与下,肝癌细胞总的凋亡率达85%±3%,而正常肝细胞则仅为16%±2%.结论 AF-pGL3-hTERT-TK可以靶向攻击肝癌细胞,对正常肝细胞几乎无影响,其基因传递系统具备靶向治疗肝癌的潜力.

关 键 词:癌,肝细胞  基因疗法  旁观者效应  自杀基因

Asialofetuin-hTERT-TK/GCV targeted gene therapy and its bystander effect on HepG2
YANG Chang-qing,DENG Zhi-hua,LIU Yan,LIU Jing-long,CAO Yan. Asialofetuin-hTERT-TK/GCV targeted gene therapy and its bystander effect on HepG2[J]. Chinese journal of hepatology, 2008, 16(7): 509-513
Authors:YANG Chang-qing  DENG Zhi-hua  LIU Yan  LIU Jing-long  CAO Yan
Affiliation:Department of Gastroenterology, Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
Abstract:OBJECTIVE: To observe the targeted therapeutic effects of plasmid AF-pGL3-hTERT-TK on HepG2 cells. METHODS: HepG2 cells were cultured and pGL3-hTERT-TK and AF-liposome were constructed. HepG2 and L02 cells were transfected with AF-pGL3-hTERT-TK. The growth, apoptosis of the cells and the bystander effects were studied using liquid scintillation analysis and tunnel and flow cytometry. RESULTS: After the suicide gene was inserted into the downstream of hTERT, TK was effectively driven by the hTERT promoter, making the TK highly expressed in the HepG2 cells. The AF made the therapeutic gene enter the HepG2 cells more easily by recognizing and combining the ASGPR receptor protein on the HepG2 cell surfaces and induced their apoptosis and suicide with bystander effect. The apoptosis rate was 85%+/-3% in the HepG2 cells whereas in the normal L02 hepatic cells it was 16%+/-2%. CONCLUSION: AF-pGL3-hTERT-TK can target and attack HepG2 cells and has almost no influence on normal L02 hepatic cells. AF-pGL3-hTERT-TK has a potential in the treatment of hepatocellular carcinomas.[Chinese FullText URL http://zhgz.chinajournal.net.cn].
Keywords:Carcinoma,hepatocellular  Gene therapy  Bystander effect  Suicide gene
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号